Steven Soderbergh Leaves 'Man from U.N.C.L.E.' to Take 'Bitter Pill'

November 29, 2011
Source: THR

Steven Soderbergh

Just last week Steven Soderbergh decided that his second to last film wouldn't actually be The Man from U.N.C.L.E. as the filmmaker left the project just like its potential start George Clooney did back in August. While the project would've reunited the director with writer Scott Z. Burns, the two will instead be working on a new project called The Bitter Pill which is currently being shopped around to studios. At this time there aren't any plot details to reveal except that it's a thriller set in the world of psychopharmacology. It's probably safe to say it has flares of real-world concepts in the same way Contagion did for pandemics.

THR says Lorenzo di Bonaventura (Transformers) will produce along with Soderbergh's trusted producing partner Gregory Jacobs and that makes the third film that Soderbergh, Burns and Jacobs have collaborated on following Contagion and The Informant!. Soderbergh's retirement is imminent with Magic Mike being the next film following Haywire to hit theaters, followed by this new project and concluding with Candelabra, the Liberace biopic starring Michael Douglas and Matt Damon. It will certainly be interesting to see if the filmmaker really does step away from cinema after these forthcoming projects.

Find more posts in Development, Movie News

Discover more on ZergNet:

Reader Feedback - 0 Comments

No comments yet.

Sorry, no commenting is allowed at this time.




Alex's Top 10 of 2015
1. Mad Max: Fury Road
2. Son of Saul
3. Victoria
4. Creed
5. Sherpa
6. The End of the Tour
7. Sicario
8. The Revenant
9. The Martian
10. Beasts / No Nation
Click Here for Thoughts

Jeremy's Top 10 - 2015
1. Anomalisa
2. Creed
3. Mad Max: Fury Road
4. Ex Machina
5. Room
6. The Hateful Eight
7. Spring
8. White God
9. Montage of Heck
10. Spy
Click Here for Thoughts


Subscribe to our feed or daily newsletter:
Follow Alex's main profile on twitter:
For the news posts only, follow this acct:
Add our feed to your Feedly: follow us in feedly